# KAFOCIN
> **NDA050219** · New Drug Application · Sponsor: LILLY · Approved 1970-06-12
## Drug
- **FDA Application Number:** NDA050219
- **Application type:** New Drug Application
- **Brand name:** KAFOCIN
- **Generic name:** Cephaloglycin
- **Active ingredients:** CEPHALOGLYCIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LILLY
- **First approval:** 1970-06-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050219)
---
*AI Analytics · CC0 1.0*